Peer-influenced content. Sources you trust. No registration required. This is HCN.
Specialty Pharmacy Continuum
Across the board, for all outcomes—acute pancreatitis, all-cause mortality, hospitalizations, ICU admissions—we saw significant reductions in patients on GLP-1s compared to chronic pancreatitis patients not on these drugs.” – Mahmoud Y. Madi, MD
Ambulatory Care Pharmacy October 14th 2025